Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases

Jiawen Hu,Yiwen Wang,Xiaojian Ji,Yinan Zhang,Kunpeng Li,Feng Huang

DOI: https://doi.org/10.2147/cia.s455736

IF: 3.829

2024-05-16

Clinical Interventions in Aging

Abstract:Jiawen Hu, 1, 2 Yiwen Wang, 1 Xiaojian Ji, 1 Yinan Zhang, 1 Kunpeng Li, 1 Feng Huang 1 1 Department of Rheumatology and Immunology, First Medical Center of Chinese PLA General Hospital, Beijing, China; 2 Medical School of Chinese PLA, Beijing, China Correspondence: Feng Huang, Department of Rheumatology and Immunology, First Medical Center of Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing, 100853, China, Email This article focuses on a range of non-pharmacological strategies for managing sarcopenia in chronic diseases, including exercise, dietary supplements, traditional Chinese exercise, intestinal microecology, and rehabilitation therapies for individuals with limited limb movement. By analyzing multiple studies, the article aims to summarize the available evidence to manage sarcopenia in individuals with chronic diseases. The results strongly emphasize the role of resistance training in addressing chronic diseases and secondary sarcopenia. Maintaining the appropriate frequency and intensity of resistance training can help prevent muscle atrophy and effectively reduce inflammation. Although aerobic exercise has limited ability to improve skeletal muscle mass, it does have some positive effects on physical function. Building upon this, the article explores the potential benefits of combined training approaches, highlighting their helpfulness for overall quality of life. Additionally, the article also highlights the importance of dietary supplements in combating muscle atrophy in chronic diseases. It focuses on the importance of protein intake, supplements rich in essential amino acids and omega-3, as well as sufficient vitamin D to prevent muscle atrophy. Combining exercise with dietary supplements appears to be an effective strategy for preventing sarcopenia, although the optimal dosage and type of supplement remain unclear. Furthermore, the article explores the potential benefits of intestinal microecology in sarcopenia. Probiotics, prebiotics, and bacterial products are suggested as new treatment options for sarcopenia. Additionally, emerging therapies such as whole body vibration training, blood flow restriction, and electrical stimulation show promise in treating sarcopenia with limited limb movement. Overall, this article provides valuable insights into non-pharmacological strategies for managing sarcopenia in individuals with chronic diseases. It emphasizes the importance of a holistic and integrated approach that incorporates exercise, nutrition, and multidisciplinary interventions, which have the potential to promote health in the elderly population. Future research should prioritize high-quality randomized controlled trials and utilize wearable devices, smartphone applications, and other advanced surveillance methods to investigate the most effective intervention strategies for sarcopenia associated with different chronic diseases. Keywords: sarcopenia, resistance training, nutrition, chronic disease, inflammation Sarcopenia, a progressive skeletal muscle disease characterized by a decline in muscle mass, muscle strength, and physical function, was first proposed by Rosenberg in 1989. However, it was not until 2010 that the European Working Group on Sarcopenia (EWGSOP) published a consensus 1 defining it as a progressive, systemic loss of muscle mass and/or decreased muscle strength or decreased physiological muscle function associated with aging. As the global population ages, the prevalence of sarcopenia has also increased, leading to reduced mobility, increased frailty, a higher risk of falls and fractures, and placing a heavy burden on families and society. 2 According to the EWGSOP estimation, the global prevalence of sarcopenia is projected to reach 1.2 billion by 2025 and 2 billion by 2050. Even with conservative estimates, it is expected that the affected population will exceed 200 million in the next four decades. Nowadays, the pathogenesis of sarcopenia is not fully understood. The natural loss of muscle mass in the elderly is classified as primary sarcopenia, while muscle loss resulting from other causes, such as reduced hormone levels involved in maintaining muscle mass, decreased physical activity, anabolic resistance, nutritional status, inflammation, mitochondrial dysfunction, and chronic diseases, is classified as secondary sarcopenia. 3 The EWGSOP also emphasized the importance of recognizing subclasses of sarcopenia in the consensus revision, such as acute sarcopenia due to acute disease or injury, and chronic sarcopenia due to inflammatory diseases. Managing these subclasses requires additional attention. 4 To prevent and manage sarcopenia, experts recommend resistance training (RT) along with dietary supplements. Ch -Abstract Truncated-

geriatrics & gerontology,gerontology